Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

PARP Inhibitors in Cancer Diagnosis and Therapy.

Chan CY. et al, (2021), Clin Cancer Res, 27, 1585 - 1594

Emerging chelators for nuclear imaging.

CORNELISSEN B. and SNEDDON D., (2021), Current Opinion in Chemical Biology

A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear Epitopes

Veal M. et al, (2021), Journal of Nuclear Medicine

Combination Strategies to Improve Targeted Radionuclide Therapy.

Chan TG. et al, (2020), J Nucl Med, 61, 1544 - 1552

Exploring the limits of intranuclear PET/SPECT imaging with IgG-TAT: how low can you go?

Veal M. et al, (2020), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47, S78 - S78

Imaging tumour CD8+T-cell infiltrates following radioimmunotherapy in an immunocompetent mouse model

Cornelissen B. et al, (2020), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47, S162 - S163

Ratiometric relationship between gamma H2AX imaging and Lutetium-177 is predictive of survival following radionuclide therapy in vivo

O'Neill E. et al, (2020), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47, S54 - S55

Development of [18F]ICMT-11 for Imaging Caspase-3/7 Activity during Therapy-Induced Apoptosis.

García-Argüello SF. et al, (2020), Cancers (Basel), 12

Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer.

Baguña Torres J. et al, (2020), J Nucl Med

A screen of 350 combination therapies with Lu-177-DOTATATE reveal distinct differences to EBRT and novel action of CDK4/6 inhibitors

ONeill E. et al, (2020), JOURNAL OF NUCLEAR MEDICINE, 61

Radiolabelled cCPE mutants allow selective imaging of claudin-4 in mouse models of PDAC

BAGUNA TORRES J. et al, (2020), The Journal of Nuclear Medicine

[18F]AZD2461, an insight on difference in PARP binding profiles for DNA damage response PET imaging

GUIBBAL F. et al, (2020), Molecular Imaging and Biology

Manual and automated Cu-mediated radiosynthesis of the PARP inhibitor [18F]olaparib.

Guibbal F. et al, (2020), Nat Protoc, 15, 1525 - 1541

Immuno-imaging of ICAM-1 in tumours by SPECT

Mosley M. et al, (2020), Nuclear Medicine and Biology

18F-Trifluoromethanesulfinate enables Direct C-H 18F-Trifluoromethylation of Native Aromatic Residues in Peptides.

Kee CW. et al, (2020), J Am Chem Soc

89Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma.

Poty S. et al, (2020), Theranostics, 10, 5802 - 5814

Imaging DNA Damage Repair in vivo Following 177Lu-DOTATATE Therapy.

O'Neill E. et al, (2019), J Nucl Med

Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signalling

CORNELISSEN B. et al, (2019), The Journal of Nuclear Medicine

Development of novel Ga-68 chelators for PET imaging

Sneddon D. et al, (2019), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 46, S728 - S729

Imaging [F-18]olaparib in malignant glioma models

Hopkins SL. et al, (2019), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 46, S685 - S685

Load More

1
2
3
4
5
6
7
...
»